SPOTLIGHT -
Exploring the Use of Tisagenlecleucel for Patients With Lymphoma
Stephen J. Schuster, MD, discusses tisagenlecleucel in adult patients with relapsed/refractory follicular lymphoma in the phase 2 Elara trial and the 5-year follow-up of a smaller CAR T-cell trial.
